olmesartan has been researched along with D-fructopyranose in 2 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (D-fructopyranose) | Trials (D-fructopyranose) | Recent Studies (post-2010) (D-fructopyranose) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 18,095 | 1,041 | 5,633 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Ichiki, T; Imayama, I; Inanaga, K; Miyazaki, R; Ohtsubo, H; Sunagawa, K | 1 |
| Abo El-Nasr, NME; Hashad, IM; Saleh, DO | 1 |
2 other study(ies) available for olmesartan and D-fructopyranose
| Article | Year |
|---|---|
Inhibition of balloon injury-induced neointimal formation by olmesartan and pravastatin in rats with insulin resistance.
Topics: Angioplasty, Balloon; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Carotid Artery Diseases; Carotid Artery Injuries; Carotid Artery, Common; Cell Count; Cell Proliferation; Fructose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Immunohistochemistry; Insulin Resistance; Male; Pravastatin; Rats; Rats, Sprague-Dawley; Stem Cells; Tetrazoles | 2007 |
Role of olmesartan in ameliorating diabetic nephropathy in rats by targeting the AGE/PKC, TLR4/P38-MAPK and SIRT-1 autophagic signaling pathways.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fructose; Imidazoles; Kidney; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Signal Transduction; Sirtuins; Streptozocin; Tetrazoles; Toll-Like Receptor 4 | 2022 |